These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20083627)

  • 1. Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure.
    Cleland JG; Coletta AP; Freemantle N; Ahmed D; Rubis P; Clark AL
    Eur J Heart Fail; 2010 Feb; 12(2):197-201. PubMed ID: 20083627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol: a review of its use in chronic heart failure.
    Keating GM; Jarvis B
    Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study.
    Shelton RJ; Velavan P; Nikitin NP; Coletta AP; Clark AL; Rigby AS; Freemantle N; Cleland JG;
    Eur J Heart Fail; 2005 Jan; 7(1):127-35. PubMed ID: 15642544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of heart failure: an update].
    Sinagra G; Perkan A; Cherubini A; Salvatore L; Di Lenarda A
    Ital Heart J Suppl; 2002 Jul; 3(7):691-7. PubMed ID: 12187629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.
    Cleland JG; Coletta AP; Abdellah AT; Cullington D; Clark AL; Rigby AS
    Eur J Heart Fail; 2008 Jan; 10(1):102-8. PubMed ID: 18179987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
    Stecker EC; Fendrick AM; Knight BP; Aaronson KD
    Am Heart J; 2006 Apr; 151(4):820-8. PubMed ID: 16569541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
    Krum H; Mohacsi P; Katus HA; Tendera M; Rouleau JL; Fowler MB; Coats AJ; Roecker EB; Packer M;
    Am Heart J; 2006 Jan; 151(1):55-61. PubMed ID: 16368292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal hyperactivity in heart failure. Differences in beta blockers].
    Beuckelmann DJ
    Herz; 2002 Aug; 27 Suppl 1():9-15. PubMed ID: 12229258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol in heart failure.
    Kelly DT
    Cardiology; 1993; 82 Suppl 3():45-9. PubMed ID: 8106165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study.
    Nagatomo Y; Yoshikawa T; Okamoto H; Kitabatake A; Hori M;
    J Card Fail; 2015 Mar; 21(3):198-207. PubMed ID: 25528200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.